April 10, 2017 Bio/Pharma/CRO M&A, Partnerships Product Launch

GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies

Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic... Read more

April 10, 2017 Bio/Pharma/CRO PR/Corporate

Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer

Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more

April 5, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Phase I Clinical Trial Examines Safety of Using Cord Blood Stem Cells for Treating Children with Autism Spectrum Disorder

Preliminary Findings Indicate Potential Efficacy of Cord Blood to Improve the Lives of Children with Social and Behavioral Challenges Associated with ASD WALTHAM, Mass. –  April 5, 2017–  Novel research results from Duke University’s Robertson Clinical and Translational Cell Therapy Program published today in the April issue of Stem Cells Translational Medicine indicate promising developments... Read more

April 3, 2017 Bio/Pharma/CRO Informatics & Software Lab Top-10

New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research

New Cloud-Based PerkinElmer Signals™ Notebook Helps Scientists Accelerate Drug Discovery Research WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the PerkinElmer Signals™ Notebook at the American Chemical Society (ACS) Spring National Meeting and Exposition Booth #619 PerkinElmer’s new cloud-based Electronic Laboratory Notebook solution (ELN)... Read more

April 3, 2017 Bio/Pharma/CRO M&A, Partnerships

GE Healthcare signs agreement with HealthTrust to supply radiopharmaceuticals

CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017. Marco... Read more

March 29, 2017 Bio/Pharma/CRO Informatics & Software Mass Spectrometry

SCIEX Announces New Biotransformation Solutions for Routine and Comprehensive Metabolism and Biologic Catabolism Studies

Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. March 29, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution... Read more

March 13, 2017 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Wauwatosa, Wisconsin – 13 March 2017 – Monitoring expectant mothers and their babies before and during childbirth is a vital and at times a complicated task. GE Healthcare is investing in innovations to make it easier. Today, GE Healthcare announced that it is expanding its Maternal-Infant Care business with the acquisition of Monica Healthcare, a... Read more

March 9, 2017 Acad, Gov/Utilities Bio/Pharma/CRO Industrial M&A, Partnerships

VWR Signs European Distribution Agreement for J.T.Baker® and Macron Fine Chemicals™ Laboratory Pharmaceutical and Production Chemistries

Radnor, PA – March 9, 2017 – VWR (NASDAQ: VWR), the leading global independent provider of products and service solutions to laboratory and production customers, is excited to announce an agreement with Avantor® Performance Materials, LLC. This agreement will allow VWR to distribute Avantor’s beaker-to-bulk portfolio of J.T.Baker® and Macron Fine Chemicals™ brand laboratory and... Read more

March 1, 2017 Bio/Pharma/CRO Product Launch

GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent Clariscan

VIENNA, AUSTRIA – 1 March, 2017 – Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ (gadoteric acid) at the European Congress of Radiology (ECR) 2017 meeting. Clariscan is a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of... Read more